Summary
Biogen Inc. filed an 8-K on May 26, 2006, primarily detailing changes and approvals related to its non-employee director compensation structure. The key event was the stockholder approval of the 2006 Non-Employee Directors Equity Plan at the annual meeting. This plan will govern future equity grants to directors. The company's Board of Directors also made adjustments to the compensation period for non-employee directors, shifting it from a calendar year to a period aligned with the annual meeting cycle. Following these approvals, specific equity grants, including stock options and restricted stock units, were awarded to all non-employee directors and the Chairman of the Board under the new plan, with vesting tied to a year of service.
Key Highlights
- 1Stockholders approved the 2006 Non-Employee Directors Equity Plan at the May 24, 2006 annual meeting.
- 2The compensation period for non-employee directors has been adjusted to align with the annual meeting cycle, effective from the 2006 meeting.
- 3Each of the ten non-employee directors received a grant of a ten-year stock option to purchase 3,125 shares at $46.99 and 1,250 restricted stock units.
- 4All equity grants to non-employee directors vest after one year of service from May 25, 2006.
- 5The Chairman of the Board, Bruce R. Ross, received an additional annual retainer of $60,000.
- 6Mr. Ross was also granted a larger equity package: a ten-year stock option for 6,250 shares at $46.99 and 2,500 restricted stock units, also vesting after one year.
- 7These equity awards are granted under the newly approved Directors Equity Plan.
Frequently Asked Questions
The main purpose of this 8-K filing is to report on the stockholder approval of Biogen Inc.'s 2006 Non-Employee Directors Equity Plan and subsequent equity grants made to its non-employee directors and Chairman of the Board.
The stock options granted to directors have a ten-year term and are exercisable upon completion of one year of service from May 25, 2006. The restricted stock units also fully vest upon completion of one year of service from May 25, 2006.
Yes, the annual period for director compensation has been changed from a calendar year to an approximately one-year period between annual stockholder meetings. Additionally, equity grants are now part of the standard compensation package under the new Directors Equity Plan, and the Chairman of the Board receives a specific annual retainer.
The exercise price for all stock options granted to non-employee directors and the Chairman of the Board is $46.99 per share.